Revvity Inc vs Target Corporation — how do they compare? Revvity Inc trades at $110.7 (market cap $11.87B), while Target Corporation trades at $138.64 (market cap $63.40B). The key difference: Target Corporation is far larger — about 5.3× Revvity Inc's market cap, and Target Corporation pays the higher dividend (3.32%). Which is the better fit depends on your goals.
| RVTY | TGT | |
|---|---|---|
Market Cap | $11.87B | $63.40B |
Sector | Technology | Consumer Cyclical |
52-Week High | $117.75 | $141.19 |
52-Week Low | $82.26 | $83.68 |
Enterprise Value | $14.36B | $78.70B |
Dividend Yield | 0.26% | 3.32% |
Trailing returns across standard periods
Latest headlines on both assets
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →With 1,926 stores (as of the end of fiscal 2021), Target is a leading American general merchandise retailer, offering a variety of products across several categories, including beauty and household essentials (26% of fiscal 2021 sales), food and beverage (19%), home furnishings and décor (19%), hardlines (18%), and apparel and accessories (17%). Most of Target's stores are large, averaging more than 125,000 square feet. The company has a significant e-commerce presence, deriving around 19% of sales from the channel (up from about 9% in fiscal 2019, before the pandemic). In addition to its namesake stores, Target owns Shipt, an online same-day delivery platform. After it exited Canada in 2015, virtually all of Target's revenue is generated from the United States.
Read more on TGT →